Ferrous Sulfate
- Generic Name
- Ferrous Sulfate
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- FeO4S
- CAS Number
- 7720-78-7
- Unique Ingredient Identifier
- 2IDP3X9OUD
- Background
Iron deficiency anemia is a large public health concern worldwide, especially in young children, infants, and women of childbearing age. This type of anemia occurs when iron intake, iron stores, and iron loss do not adequately support the formation of erythrocytes, also known as red blood cells.
...
- Indication
抗贫血药。用于预防和治疗各种原因引起的缺铁性贫血，包括儿童或婴儿期需铁量增加而食物中供应不足、铁吸收障碍、妊娠中后期以及慢性失血等。
- Associated Conditions
- Anaemia folate deficiency, Anemia, Folate deficiency, Iron Deficiency (ID), Iron Deficiency Anemia (IDA), Hypochromic anemia
- Associated Therapies
- Iron replacement therapy
Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA
- First Posted Date
- 2024-08-13
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Loma Linda University
- Target Recruit Count
- 100
- Registration Number
- NCT06550362
Sucrosomial Iron and Iron Sulphate to Blood Donors
- Conditions
- Interventions
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- Uppsala University Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT05678647
- Locations
- 🇸🇪
Clinical Immunology and Transfusion Medicine, Uppsala University Hospital, Uppsala, Sweden
An Open Study on the Efficacy of Iron Therapy Using iv Iron Relative to Oral Iron for Increasing LV Systolic Function
- Conditions
- Interventions
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- Kazan State Medical University
- Target Recruit Count
- 360
- Registration Number
- NCT05309499
- Locations
- 🇷🇺
Kazan State Medical Universety, Kazan, Tatarstan, Russian Federation
Iron Supplementation and Neurodevelopmental Outcome in ELGANs
- First Posted Date
- 2020-12-31
- Last Posted Date
- 2024-11-12
- Target Recruit Count
- 51
- Registration Number
- NCT04691843
- Locations
- 🇺🇸
Prentice Women's Hospital, Chicago, Illinois, United States
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
- Conditions
- Interventions
- First Posted Date
- 2019-05-21
- Last Posted Date
- 2022-06-27
- Lead Sponsor
- University Medical Centre Ljubljana
- Target Recruit Count
- 300
- Registration Number
- NCT03957057
- Locations
- 🇸🇮
UMC Ljubljana, Ljubljana, Slovenia
Ulipristal Use in Chinese Population
- Conditions
- Interventions
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2020-04-09
- Lead Sponsor
- Queen Mary Hospital, Hong Kong
- Target Recruit Count
- 31
- Registration Number
- NCT02825719
- Locations
- 🇭🇰
Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong, Hong Kong
Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
- Conditions
- Interventions
- First Posted Date
- 2016-05-17
- Last Posted Date
- 2017-01-25
- Lead Sponsor
- American University of Beirut Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT02774057
- Locations
- 🇱🇧
American University of Beirut - Medical Center, Beirut, Lebanon
Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2017-05-09
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 90
- Registration Number
- NCT01991314
- Locations
- 🇬🇧
Barts Health NHS Trust, London, United Kingdom
IVICA: Intravenous Iron in Colorectal Cancer Associated Anaemia
- Conditions
- Interventions
- First Posted Date
- 2012-10-05
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- Nottingham University Hospitals NHS Trust
- Target Recruit Count
- 116
- Registration Number
- NCT01701310
- Locations
- 🇬🇧
University Hospital Birmingham, Birmingham, West Midlands, United Kingdom
🇬🇧Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, West Midlands, United Kingdom
🇬🇧St James University Hospitals NHS Trust, Leeds, United Kingdom
Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia
- Conditions
- Interventions
- First Posted Date
- 2012-06-27
- Last Posted Date
- 2016-08-03
- Lead Sponsor
- Dow University of Health Sciences
- Target Recruit Count
- 271
- Registration Number
- NCT01628770
- Locations
- 🇵🇰
Dow University of Health Sciences, Karachi, Sindh, Pakistan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.